Skip to main content
Translational Neurodegeneration logoLink to Translational Neurodegeneration
. 2019 Mar 19;8:10. doi: 10.1186/s40035-019-0150-3

Correction to: Better survival in female SOD1-mutant patients with ALS: a study of SOD1-related natural history

Lu Tang 1, Yan Ma 1, Xiao-lu Liu 1, Lu Chen 1, Dong-sheng Fan 1,
PMCID: PMC6423817  PMID: 30923611

Correction to: Transl Neurodegener (2019) 8:2

https://doi.org/10.1186/s40035-018-0142-8

In the original publication of this article [1], a numerical value in the sentence “The mean (SD) AAO was 43.92 years (9.24) for all subjects, with a significant difference between patients carrying mutations in exon 2 (n = 24, 46.83, 8.31) and exon 4 (n = 18, 37.75, 7.67) (p = 0.002).” is wrong. The true value in the parenthesis of exon 2 should be (n = 24, 46.63, 8.31).

Reference

  • 1.Tang L, et al. Better survival in female SOD1-mutant patients with ALS: a study of SOD1-related natural history. Transl Neurodegener. 2019;8:2. doi: 10.1186/s40035-018-0142-8. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Translational Neurodegeneration are provided here courtesy of BMC

RESOURCES